Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

New D4 antagonist may aid in the search for antipsychotic drugs

Aug. 25, 1997

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Microtubule inhibitor with low toxicity and unique profile of CaM activity

Aug. 25, 1997

Indomethacin prodrug with potent antiinflammatory effects, low ulcerogenicity

Aug. 25, 1997

New COX-2 inhibitor series reported by Searle

Aug. 22, 1997

Nonpeptide CRF1 antagonist reduces cerebral infarction in rats

Aug. 21, 1997

Antimigraine agent in pharmacokinetic testing at HMR

Aug. 20, 1997

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

Imidazoline derivative displays potent antidiabetic effects in rats

Aug. 20, 1997

Digestive tract marker evaluated in diabetic patients with gastroenteropathies

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...